NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹285 Cr | ₹243 Cr | ₹249 Cr | ₹178 Cr | ₹13,192,719 Cr |
What is the latest Total Expenditure of NGL FINECHEM ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹285 Cr |
| Mar2024 | ₹243 Cr |
| Mar2023 | ₹249 Cr |
| Mar2022 | ₹178 Cr |
| Mar2021 | ₹13,192,719 Cr |
How is Total Expenditure of NGL FINECHEM Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹285 Cr | 17.20 | |
| Mar2024 | ₹243 Cr | -2.48 | |
| Mar2023 | ₹249 Cr | 40.17 | |
| Mar2022 | ₹178 Cr | -100.00 | |
| Mar2021 | ₹13,192,719 Cr | - | |
Compare Total Expenditure of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,962.4 Cr | -1.1% | 1.7% | 156.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -1.1% |
1.7% |
156.4% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses